All Posts

How a single immune-cell treatment led to drug-free remission in severe autoimmune disease

Microbiome-derived metabolites boost gut regeneration after stem cell transplantation, offering a targeted alternative to microbiome therapies.

Ultra-processed foods are reshaping modern diets. A Lancet review explains how processing, not just nutrients, affects disease risk.

Antidepressants affect more than mood. A new Lancet meta-analysis reveals major differences in weight, blood pressure, and metabolic risk.

Early-onset type 2 diabetes is more aggressive than expected. A Lancet review explains why earlier diagnosis changes lifetime risk.

What one of the biggest vaccine reviews of the year means for individuals, clinicians and for health systems like Switzerland’s.

What if the heart could heal itself? New research shows adult human heart cells may divide again. A hint at real regeneration?

AI-designed CRISPR 3.0 editors bring safer, more precise gene editing closer to reality, opening a new era of future therapies.

Could teeth repair themselves? A protein gel from Nottingham shows the most advanced enamel regeneration yet.

Scientists map the human sweet-taste receptor in atomic detail — paving the way for healthier sugar alternatives.

Hidden in forest soil: a new molecule that might restart the antibiotic era.

A gentle seaweed gel challenges medicine’s old rule: more adhesion doesn’t mean better healing.

New study reveals: Depression isn’t just chemical, it’s cellular. Neurons and microglia show distinct molecular changes.

Hidden repair code in your eyes? New research uncovers “pliancy genes” that could make retinal cells self-heal.

AI turns a simple blood test into a life-saving tool — predicting sepsis risk before symptoms become critical.

RSV causes 11M cases in seniors yearly. New vaccines show 80% protection — a turning point for prevention and policy.

Will Switzerland become the AI hub for precision oncology? New insights from Cancer Cell and the NAIPO initiative.

Harvard study: Lithium orotate reverses Alzheimer’s symptoms in mice – a potential low-cost breakthrough for patients and healthcare.